The majority of Investor Relations Managers at Sunovion Pharmaceuticals believe they're not compensated fairly. 67% of Investor Relations Managers at Sunovion Pharmaceuticals say they receive annual bonuses, and the vast majority (80%) are satisfied with their benefits. See more compensation ratings at Sunovion Pharmaceuticals